Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA; CHARM Committees and Investigators. O'Meara E, et al. Among authors: pocock s. Circulation. 2006 Feb 21;113(7):986-94. doi: 10.1161/CIRCULATIONAHA.105.582577. Epub 2006 Feb 13. Circulation. 2006. PMID: 16476847
Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial.
Sculpher M, Smith D, Clayton T, Henderson R, Buxton M, Pocock S, Chamberlain D; Randomized Intervention Treatment of Angina (RITA-2) trial. Sculpher M, et al. Among authors: pocock s. Eur Heart J. 2002 Aug;23(16):1291-1300. doi: 10.1053/euhj.2001.3075. Eur Heart J. 2002. PMID: 12175666 Clinical Trial.
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.
Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ; Randomized Intervention Trial of unstable Angina Investigators. Fox KA, et al. Among authors: pocock sj. Lancet. 2002 Sep 7;360(9335):743-51. doi: 10.1016/s0140-6736(02)09894-x. Lancet. 2002. PMID: 12241831 Clinical Trial.
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy.
Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KA, Julian DG, Chamberlain DA; Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Henderson RA, et al. J Am Coll Cardiol. 2003 Oct 1;42(7):1161-70. doi: 10.1016/s0735-1097(03)00951-3. J Am Coll Cardiol. 2003. PMID: 14522473 Free article. Clinical Trial.
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3).
Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KA; RITA-3 Trial Investigators. Kim J, et al. J Am Coll Cardiol. 2005 Jan 18;45(2):221-8. doi: 10.1016/j.jacc.2004.10.034. J Am Coll Cardiol. 2005. PMID: 15653019 Free article. Clinical Trial.
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA; Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Solomon SD, et al. Among authors: pocock s. Circulation. 2005 Dec 13;112(24):3738-44. doi: 10.1161/CIRCULATIONAHA.105.561423. Epub 2005 Dec 5. Circulation. 2005. PMID: 16330684 Clinical Trial.
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Hillege HL, et al. Among authors: pocock s. Circulation. 2006 Feb 7;113(5):671-8. doi: 10.1161/CIRCULATIONAHA.105.580506. Circulation. 2006. PMID: 16461840
817 results